GLP-1 users face 6 rebound risks after stopping the weight-loss drugs
By
asserted
users → face → drugs
While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.
asserted
patients → reshape → year
Research has found that cycling off these medications can bring potential rebound risks, ranging from rapid weight regain to the loss of cardiovascular protection.
asserted
cycling → find → protection
Dr. Frank Dumont, internal medicine physician and executive medical director at Virta Health in San Francisco, spoke with Fox News Digital about why patients stop taking GLP-1s, the potential risks and how to maintain progress afterward.
asserted
patients → speak → progress
Why patients stop
Some patients may stop taking GLP-1 medications because of medical concerns or side effects, while others prefer not to remain on long-term medication, Dumont said.
uncertain
Dumont → stop → medication
Common side effects include nausea, vomiting, constipation and diarrhea.
asserted
effects → include → nausea
“Those types of things can become troublesome enough that people actually have a hard time eating enough food to get good nourishment,” he told Fox News Digital.
asserted
he → become → Digital
“Working with your physician to make a decision about whether it’s right for you to stay on the medicine or not is important.
asserted
you → work → medicine
Other serious side effects, like acute pancreatitis, would prompt immediate discontinuation of the drug.
asserted
effects → prompt → drug
“We know that’s fairly rare, but if the pancreas becomes involved, that is not a good thing,” Dumont said.
asserted
Dumont → know → ?
It can even be life-threatening.”
asserted
It → threaten → ?
Certain GLP-1 medications carry a warning about thyroid tumors based on animal studies, though the risk in humans remains unknown.
asserted
risk → carry → humans
These medications should not be used by people with a personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia syndrome type 2 (MEN 2).
asserted
medications → use → carcinoma
Dumont outlined six potential risks patients may face after stopping a GLP-1.
No. 1: Return of hunger and cravings
The most immediate side effect patients notice after stopping a GLP-1 is the return of intense cravings and a sharp spike in appetite, often referred to as “food noise,” according to Dumont.
uncertain
patients → outline → Dumont
Many patients assume they can treat GLP-1s like a short-term prescription, taking the drug to hit a target weight or blood sugar goal and then stopping, the doctor noted.
asserted
doctor → assume → goal
However, major medical organizations, including the American Medical Association (AMA) and the Obesity Medicine Association, classify obesity as a chronic condition that typically requires ongoing management.
asserted
that → include → management
“Unless you have significantly changed what you’re doing in terms of the types of foods you’re eating, it’s likely you’ll go back to the same foods you were eating before, and hunger and cravings will go up,” Dumont said.
asserted
Dumont → change → foods
No. 2: Weight regain
It is typical for GLP-1 users to experience weight regain after quitting, according to Dumont.
uncertain
users → experience → Dumont
In the STEP 1 trial extension, participants regained about two-thirds of the weight they had lost within a year of stopping semaglutide and lifestyle interventions.
asserted
they → regain → semaglutide
In the SURMOUNT-4 trial for tirzepatide, patients who were switched to a placebo after 36 weeks of treatment regained more than half the weight they had lost over the following year, even while receiving diet and exercise counseling.
“That’s just so devastating for people who felt like they’d finally found a solution that would work,” Dumont said.
asserted
Dumont → switch → solution
No. 3: Change in biomarkers
Biomarkers — which are measurable indicators of what’s happening inside the body, such as blood sugar, blood pressure and cholesterol levels — tend to improve while taking a GLP-1, which is beneficial for those with prediabetes or diabetes.
asserted
which → happen → prediabetes
When a GLP-1 is stopped, these markers can reverse if not countered with a change in diet, according to Dumont.
uncertain
markers → stop → Dumont
Improvements in fatty liver disease may also fade after treatment stops, the doctor said.
uncertain
doctor → fade → disease
“We know that these medications can help to decrease some of that steatotic or fatty liver disease that occurs,” he noted.
asserted
he → know → disease
“And when you go off the medicine, if you go back to eating the way you did before, those numbers have a tendency to worsen.”
asserted
numbers → go → tendency
“When people take the GLP-1 medications, they lose weight, but they tend to lose both fat mass and lean muscle mass,” he told Fox News Digital.
asserted
he → take → Digital
In a body-composition study of tirzepatide, about 25% of the weight lost was lean mass, which includes muscle and other nonfat tissue.
asserted
which → lose → muscle
The remaining 75% was fat.
asserted
% → remain → ?
Dumont expressed concern that patients who regain weight after stopping treatment may not fully replace the muscle they lost.
uncertain
they → express → muscle
“So, there’s a bit of a ratcheting-down effect if someone is on and off these medications, where they lose fat and muscle, stop the medicine, regain fat, go back on the medicine, and lose fat and muscle,” he added.
asserted
he → ’ → fat
The doctor emphasized that preserving muscle is important for metabolism, injury prevention and everyday activities.
asserted
preserving → emphasize → metabolism
In addition to the physical consequences, Dumont noted that stopping a weight-loss drug can take a heavy toll on mental health.
asserted
stopping → note → health
Many patients have spent years cycling through diets and programs without lasting success, often viewing GLP-1s as a final solution, according to the doctor.
Keep up with today’s most important news
Stay up on the very latest with Evening Update.
When the medication isn’t right for them — adding to a history of past weight-loss setbacks — experiencing a “regression on all fronts” can be “really devastating from a mental health standpoint,” Dumont said.
“It can make you feel disheartened and like you don’t have the control you thought you did,” he added.
uncertain
he → spend → control
No. 6: Loss of health protection
An observational study published in BMJ Medicine found that adults with type 2 diabetes who stopped GLP-1 treatment had a higher risk of major cardiovascular events than those who continued.
asserted
who → publish → those
Longer periods without treatment were associated with greater risk.
asserted
periods → associate → risk
Dumont noted that the stakes of stopping a GLP-1 go far beyond weight, pointing to the broader risk of losing metabolic benefits.
asserted
stakes → note → benefits
While taking a GLP-1, lower inflammation and improved cholesterol and blood sugar levels help reduce the risk of major events like heart attacks and strokes, the doctor said.
asserted
doctor → take → attacks
“But again, if you stop the medicine and you haven’t changed the way that you eat, then all of those numbers can worsen … and that can then increase the risk of those bad things happening — things that can be devastating from a life quality standpoint, but also can shorten your life,” he warned.
asserted
he → stop → life
Making your progress last
Reaching metabolic goals and making lasting lifestyle changes may help patients maintain their progress after stopping a GLP-1, according to Dumont.
uncertain
patients → make → Dumont
“We actually have peer-reviewed published data demonstrating that you can indeed stop one of these medications when you reach your metabolic goals,” he said.
asserted
he → have → goals
…and 5 more, not listed.